Private Capital Group’s CureVac CVAC Stock Holding History

Private Capital Group’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21	Closed	-$2K	–	2159
2021 Q2	$2K	Buy	+21	New	+$2.1K	﹤0.01%	1827

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Private Capital Group's CVAC Position: Q3 2021 in Review

Private Capital Group sold out of CureVac (CVAC) in Q3 2021, closing a stake of 21 shares — an estimated $2K sold.

Private Capital Group first reported a position in CVAC in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

Private Capital Group reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
Private Capital Group sold 21 CureVac shares in Q3 2021, an estimated $2K.
Private Capital Group first reported a position in CureVac in Q2 2021 and held it in 1 quarter.
Private Capital Group's CureVac position peaked at $2K in Q2 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Private Capital Group's 13F filing for Q3 2021, filed 13 Oct 2021.